Company Profile of Hubei Klavi Biopharm Co., Ltd.

Hubei Klavi Biopharm Co., Ltd. is a high-tech enterprise engaged in R&D, manufacturing, marketing and sales of intermediates & APIs derived from fermentation and chemical synthesis, especially in the field of ergot derivatives. We have our own GMP facility, 9 production units with 410 mt fermentation capacity (to be expanded to 1000 mt) and 10mt chemical synthesis reactors capacity to produce our featured products: Nicergoline; Methylergonovine Maleate (MEM); Ergonovine Maleate; Cabergoline; Demeclocycline Hydrochloride (DMCT);  Fusidic Acid; Sodium Fusidate and Josamycin.